- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2014
- Public Summary Document (PSD) March 2014 PBAC Meeting - PDF
Pertuzumab – March 2014
PERTUZUMAB, 420 mg/14 mL injection, 1 x 14 mL vial Perjeta®, Roche Products Pty Ltd
Last updated
8 November 2023